Background: Physical functional capacity is impaired in idiopathic pulmonary fibrosis (IPF). There is no tool to measure this key clinical outcome. The continuous-scale physical function performance (CS-PFP) test is one that assesses activities of daily living, but it has never been used in IPF.
Methods: We determined internal consistency of the CS-PFP. We used correlations to assess the strength of association between CS-PFP scores and various parameters of IPF severity, and compared the CS-PFP scores between patients with IPF and published values from a healthy control group.
Results: Sixteen subjects completed the test and retest. Test-retest reliability (0.84, p = 0.003) and internal consistency (Cronbach's α = 0.91) were excellent. Subjects with IPF had significantly worse CS-PFP scores than controls (46.0 ± 11.1 vs 58.7 ± 12.5, p = 0.001). In IPF, the CS-PFP scores correlated moderately to very strongly with several disease severity variables.
Conclusion: The CS-PFP is a reliable and valid tool in IPF.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1586/17476348.2015.1030396 | DOI Listing |
Eur J Trauma Emerg Surg
December 2023
Department of Orthopaedic Surgery and Traumatology, Inselspital, University Hospital Bern, University of Bern, Freiburgstrasse 18, 3010, Bern, Switzerland.
Purpose: This study aims to investigate the lower extremity loading during activities of daily living (ADLs) using the Continuous Scale of Physical Functional Performance (CS-PFP 10) test and wireless sensor insoles in healthy volunteers.
Methods: In this study, 42 participants were recruited, consisting of 21 healthy older adults (mean age 69.6 ± 4.
J Am Med Dir Assoc
January 2019
Pennington Biomedical Research Center, Baton Rouge, LA.
Objectives: Body composition alterations occur during aging. The purpose of the present analysis was to explore the functional consequences of the overlap of sarcopenia and osteoporosis, and the potential role of insulin-like growth factor 1 (IGF1) in their development in the oldest old.
Setting And Participants: Eighty-seven nonagenarians from the Louisiana Healthy Aging Study were included.
J Aging Res
July 2017
University Center for Medicine of Aging and Rehabilitation, Felix Platter-Hospital, Basel Mobility Center, Basel, Switzerland.
Background: The Continuous-Scale Physical Functional Performance 10 Test (CS-PFP 10) quantitatively assesses physical functional performance in older adults who have a broad range of physical functional ability. This study assessed the validity and reliability of the CS-PFP 10 German version.
Methods: Forward-translations and backtranslations as well as cultural adaptions of the test were conducted.
Crit Care
July 2017
Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Research 2, Box C272, 12700 East 19th Avenue, Aurora, CO, 80045, USA.
Background: The proportion of survivors of acute respiratory failure is growing; yet, many do not regain full function and require prolonged admission in an acute or post-acute care facility. Little is known about their trajectory of functional recovery. We sought to determine whether prolonged admission influenced the trajectory of physical function recovery and whether patient age modified the recuperation rate.
View Article and Find Full Text PDFTechnol Innov
September 2016
Doctor of Physical Therapy Program, University of St. Augustine for Health Sciences, St. Augustine, FL, USA.
The Continuous Scale-Physical Functional Performance-10 (CS-PFP-10) test consists of 10 standardized daily living tasks that evaluate overall physical functional performance and performance in five individual functional domains: upper body strength (UBS), upper body flexibility (UBF), lower body strength (LBS), balance and coordination (BAL), and endurance (END). This study sought to determine the concurrent validity of the CS-PFP-10 test and its functional domains that involve the lower extremities (LBS, BAL, or END) in comparison to measures that have established validity for use in persons with transfemoral amputation (TFA). Ten TFA patients functioning at K3 or higher (Medicare Functional Classification Level) completed the study.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!